Produktbild: Drugs and the Liver: High Risk Patients and Transplantation
Band 4

Drugs and the Liver: High Risk Patients and Transplantation

97,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

29.10.2012

Abbildungen

XXI, 186 p.

Herausgeber

D. Galmarini + weitere

Verlag

Springer Netherland

Seitenzahl

186

Maße (L/B/H)

24/16/1,2 cm

Gewicht

347 g

Auflage

Softcover reprint of the original 1st ed. 1993

Sprache

Englisch

ISBN

978-94-010-5748-6

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

29.10.2012

Abbildungen

XXI, 186 p.

Herausgeber

Verlag

Springer Netherland

Seitenzahl

186

Maße (L/B/H)

24/16/1,2 cm

Gewicht

347 g

Auflage

Softcover reprint of the original 1st ed. 1993

Sprache

Englisch

ISBN

978-94-010-5748-6

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Drugs and the Liver: High Risk Patients and Transplantation
  • 1. Risk Assessment in liver transplantation focus on lung function.- 2. Biochemical basis of hepatic ischemic/reperfusion injury.- 3. Donor rating and assessment of pretransplant prognosis by use of the MEGX test.- 4. Significance of cyclosporine pharmacokinetics in liver transplantation.- 5. Cyclosporin toxicity and liver transplantation in high risk patients.- 6. Drug treatment in liver transplanted patients: antihypertensive therapy.- 7. Bacteremia after liver transplantation; few issues in selection of antibiotics for treatment and prophylaxis.- 8. Antiviral drugs.- 9. The use of antiviral drugs in liver transplant patients.- 10. Drugs, fetal liver and reproduction.- 11. Reproduction after transplantation.- 12. Reproduction after liver transplantation for B-virus hepatitis.- 13. 24 hour-hypothermic preservation of rat liver with euro-collins and UW solutions. Comparative evaluation by 31P NMR spectroscopy, biochemical assays and light microscopy.- 14. ATP content during the ischemic period as an indicator of liver viability. A phosphorus-31 NMR study.- 15. Drugs and liver disease.- 16. Liver disease and anticancer drug treatment.- 17. Pharmacokinetics of anticancer agents in patients with impaired liver function.- 18. Pathogenesis and treatment of alcoholic liver disease.- 19. Liver fibrogenesis in chronic viral and alcoholic liver disease.- 20. Hepatocellular carcinoma.- 21. Treatment of iron dependent chronic liver disease.- 22. Liver transplantation for chronic liver disease.- 23. Practical uses of OKT3.- 24. Histopatology of acute liver rejection (ALR) in OKT3 treated patients.- 25. Spin-spin relaxation times as viability parameter of liver transplantation grafts. Investigation on a pig model.- 26. Urinary 6-? hydroxycortisol as a predictor of cyclosporineblood levels.- 27. Elucidation of the metabolic pathways of cyclosporine in vitro by human liver microsomes.- 28. Fine-needle aspiration biopsy and hepatotoxicity of cyclosporin a in orthotopic liver transplantation.- 29. Effect of FK 506 and cyclosporins on model membranes studied by nuclear magnetic resonance spectroscopy.